Colon cancer patients who have the normal version of a particular gene are more likely to benefit from a combination treatment that includes adding the targeted therapy Erbitux to chemotherapy. Read the rest of this entry »
Drugs used widely to treat anemia in cancer patients may actually speed progression of the cancer in certain individuals, but researchers report they may found a way to determine who those individuals are. Read the rest of this entry »
Patients diagnosed with pancreatic cancer - which historically carries a grim prognosis - nearly doubled their overall survival when the cancer drug Gemzar was used after surgery, new research shows. Read the rest of this entry »
People who survived Hodgkin lymphoma as children have an increased risk of developing and dying from another cancer or cardiovascular disease as adults, according to a new report. Read the rest of this entry »
Adding the drug Avastin to chemotherapy lengthened progression-free survival in women with advanced breast cancer, new research shows. Read the rest of this entry »
Chemotherapy may reduce fertility in breast cancer survivors, according to a study led by researchers at Boston’s Dana-Farber Cancer Institute. Read the rest of this entry »
Compared to a decade ago, kidney cancer patients in the United States are much more likely to be diagnosed with smaller tumors in the earliest, most treatable stage of the disease, resulting in a slightly higher survival rate. Read the rest of this entry »
Using regenerative medical techniques, it may be possible to create replacement bladders for people who’ve had their bladder removed due to cancer. Read the rest of this entry »
A panel of 15 genes may help determine which patients with early-stage non-small cell lung cancer will experience a recurrence and, therefore, benefit the most from chemotherapy, a new study shows. Read the rest of this entry »
A common genetic variant increases the risk of lung cancer, even in nonsmokers, researchers report. Read the rest of this entry »